DGDA approves Oxford Covid vaccine for emergency use
Published: 08:05 PM, 4 January 2021 Updated: 08:50 PM, 4 January 2021
Drug regulator approves Oxford Covid vaccine for emergency use
Bangladesh's drug regulator approved the coronavirus vaccine developed by Oxford University for emergency use.
Director of Directorate General of Drug Administration (DGDA) Abu Hena Morshed Zaman confirmed the matter this evening.
As a result, there is no obstacle to bringing the Seram Institute vaccine into the country.
Under the proposed project, the Department of Health has proposed to set aside a total of Tk 4,314 crore 49 lakh and 17 thousand for the purchase and storage of corona vaccine. It will cost Tk 3,030 crore by June 2021 to buy the vaccine under the project. The rest of the money will be spent in phases.
The project will be presented for final approval at the Executive Committee (ECNEC) meeting of the National Economic Council on Tuesday.
Nazmul Hasan Papon, managing director of Beximco Pharmaceuticals, said, “We have officially applied for the vaccine registration today. Of course, we have already submitted all documents and got approval very quickly.
Meanwhile, the Department of Health has informed the Planning Commission that there is a possibility of getting the vaccine in between February and December this year.